SAN RAFAEL, Calif.,
Jan. 3, 2017 /PRNewswire/
-- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today
announced that Jean-Jacques Bienaimé, Chairman and Chief Executive
Officer, will participate in the 35th Annual J.P. Morgan
Healthcare Conference on Monday, January 9,
2017 at 8:30 am PT, or
11:30 am ET, in San Francisco, California. To access the live
webcast, please visit the investor section of the BioMarin
website, www.biomarin.com. A replay will also be archived on
the site for at least one week following the event.
About BioMarin
BioMarin is a global biotechnology company that develops and
commercializes innovative therapies for people with serious and
life-threatening rare disorders. The company's portfolio consists
of five commercialized products and multiple clinical and
pre-clinical product candidates.
For additional information, please visit www.biomarin.com.
Information on BioMarin's website is not incorporated by reference
into this press release.
|
Contacts:
|
|
|
Investors
|
Media
|
|
Traci
McCarty
|
Debra
Charlesworth
|
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
|
(415)
455-7558
|
(415)
455-7451
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biomarin-to-present-at-35th-annual-jp-morgan-healthcare-conference-in-san-francisco-300384505.html
SOURCE BioMarin Pharmaceutical Inc.